Stargardt Disease To Be Treated With Embryonic Stem Cells in Trial Initiated by Advanced Cell Technology

November 24, 2010

Earlier this week, Advanced Cell Technology’s request to begin treating patients with Stargardt disease (also known as fundus flavimaculatus) with embryonic stem cells in a clinical trial was approved by the FDA. This will be the second trial using human embryonic stem cells. The first being granted to Geron to treat spinal cord disease.

A multi-center trial will involve twelve patients. If the results are positive, Advanced Cell Technology anticipates filing for an IND to treat age-related macular degeneration, as well as filing to begin clinical trials in Europe in the very near future.

For all of the details, follow this link.

 

 



Comments

Jump down to form below to submit your own comments

Trackback URL
http://eyedocnews.com/003791-first-trial-to-treat-stargardt-disease-with-embryonic-stem-cells-is-approved-by-fda/trackback/

Have insights to contribute? Please submit your comment below